Clinical role of (18)F-FDG PET/CT for detection of radioactive iodine refractory differentiated thyroid cancer

In clinical settings, an estimated 10% differentiated thyroid cancer (DTC) cases become radioactive iodide refractory (RAIR), which lack a molecular marker and have fewer treatment selections. A higher uptake of (18)F-fluorodeoxyglucose ((18)F-FDG) might indicate poor prognosis for DTC. This study a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Xiaowei, Shi, Liang, Zhao, Zhenyu, Wang, Jun, Yang, Rui, Huang, Yue, Tang, Jun, Chen, Zhengguo, Wang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
6800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270557/
https://www.ncbi.nlm.nih.gov/pubmed/37327310
http://dx.doi.org/10.1097/MD.0000000000033878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270557/
https://www.ncbi.nlm.nih.gov/pubmed/37327310
http://dx.doi.org/10.1097/MD.0000000000033878

Ejemplares similares